SCYX
Scynexis Inc
NASDAQ: SCYX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.93
-0.46% today
Updated 2026-04-30
Market cap
$78.31M
P/E ratio
—
P/S ratio
3.80x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$1 – $1
Volume
0.6M
Scynexis Inc (SCYX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-41.80%
Operating margin
56.40%
ROE
-16.50%
ROA
-13.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $16.84M | $-11.48M | 14.69% | -46.23% | -68.17% |
| 2013 | $16.86M | $-30.46M | 3.27% | -42.74% | -180.70% |
| 2014 | $1.26M | $-4.23M | -1,129.78% | -1,166.16% | -337.10% |
| 2015 | $257000.00 | $-32.62M | 100.00% | -11,030.74% | -12,693.77% |
| 2016 | $257000.00 | $-29.99M | 100.00% | -10,823.74% | -11,668.87% |
| 2017 | $257000.00 | $-25.06M | 100.00% | -10,241.25% | -9,750.97% |
| 2018 | $257000.00 | $-12.47M | 100.00% | -11,666.54% | -4,851.36% |
| 2019 | $121000.00 | $-53.71M | 100.00% | -40,430.58% | -44,388.43% |
| 2020 | $12.05M | $-55.19M | -2.51% | -424.47% | -457.97% |
| 2021 | $13.16M | $-32.87M | 97.63% | -462.19% | -249.68% |
| 2022 | $5.09M | $-62.81M | 87.66% | -1,684.48% | -1,233.73% |
| 2023 | $140.14M | $67.04M | 88.85% | 51.85% | 47.84% |
| 2024 | $3.75M | $-21.29M | 100.00% | -990.84% | -568.29% |
| 2025 | $20.60M | $-8.61M | 100.00% | -78.03% | -41.79% |